JECX.JK Nitrasanata Dharma Tbk
- Market cap
- IDR 3.61T
- P/E
- 58.6x
- P/B
- 6.78x
- ROE
- 10.9%
- Dividend yield
- 1.74%
- Fundamental score
- 1.4/5
Ratios use the latest price and the fiscal year ending Dec 2025.
Is JECX.JK undervalued?
Graham numberThe Graham number of Nitrasanata Dharma Tbk cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nitrasanata Dharma Tbk fundamental analysis
7 of 22 checks passedROE 1/2
Moderate return on equity (12.7%), between 10% and 20%.
ROA 1/1
Return on assets (4.7%) is above the industry median (2.5%).
Profit Consistency 1/2
Profitable for 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (16.0%) is below the industry median (28.6%).
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (33.6%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
EBIT is 4.8x against interest expense, below 5x.
PE vs Market 0/1
PE (62.9x) is above the market median (12.0x).
PE vs Industry 0/1
PE (62.9x) is above the industry median (27.5x).
PBV 0/1
Price to book (7.3x) is above the industry median (5.0x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 457.0, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 1/2
Dividend yield (1.6%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 86.8%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Nitrasanata Dharma Tbk stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nitrasanata Dharma Tbk
PT Nitrasanata Dharma operates as a provider of eye health services in Indonesia. The company provides ophthalmic services including cataract, lens and refractive surgery, glaucoma treatment, retina care, okuloplasty and orbital reconstruction, pediatric ophthalmology and strabismus management, contact lens services, infection and immunology care, neuro-ophthalmology, dry eye treatment, and ophthalmic trauma services. In addition, it offers solutions, such as eye check diagn…
Full company profileNitrasanata Dharma Tbk financial statements
Nitrasanata Dharma Tbk annual financial statements (IDR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 825B | 888B | 927B |
| Gross Profit | 516B | 555B | 577B |
| Operating Income | 178B | 114B | 129B |
| EBITDA | 221B | 179B | 197B |
| Net Income | 127B | 62.5B | 72.5B |
| EPS | 39 | 19 | 22 |
| Balance Sheet | |||
| Total Assets | 1.35T | 1.42T | 1.45T |
| Total Liabilities | 522B | 611B | 640B |
| Shareholders' Equity | 676B | 659B | 667B |
| Cash & Short-term Investments | 315B | 270B | 244B |
| Cash Flow | |||
| Capital Expenditure | 203B | 155B | 103B |
| Free Cash Flow | 20.0B | -11.6B | 69.9B |
| Ratios | |||
| ROE | 18.8% | 9.5% | 10.9% |
| ROA | 9.4% | 4.4% | 5.0% |
| Net Profit Margin | 15.4% | 7.0% | 7.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Nitrasanata Dharma Tbk dividends
- Dividend yield
- 1.74%
- Forward dividend
- -
- Payout ratio
- 86.8%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | IDR 62.9B | 19 | 86.8% |
| 2024 | IDR 82.8B | 25 | 132.6% |
| 2023 | IDR 66.3B | 20 | 52.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Nitrasanata Dharma Tbk
- Insiders 98.27%
- Institutions 0.00%
- Public & others 1.73%
- Shares outstanding 3.25B
- Free float 4.80M
Nitrasanata Dharma Tbk company profile
- Company name
- Nitrasanata Dharma Tbk
- Ticker
- JECX.JK
- Exchange
- Jakarta Exchange
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Employees
- 1,161
- Fiscal year end
- December
- Address
- Jl. Teuku Cik Ditiro No. 46, Jakarta Pusat, Indonesia, 10310
- Phone
- 62 21 292 2100 0
- Website
- jec.co.id
About Nitrasanata Dharma Tbk
PT Nitrasanata Dharma operates as a provider of eye health services in Indonesia. The company provides ophthalmic services including cataract, lens and refractive surgery, glaucoma treatment, retina care, okuloplasty and orbital reconstruction, pediatric ophthalmology and strabismus management, contact lens services, infection and immunology care, neuro-ophthalmology, dry eye treatment, and ophthalmic trauma services. In addition, it offers solutions, such as eye check diagnostics, tele-ophthalmology consultations, and services through the thyroid eye center. PT Nitrasanata Dharma was founded in 1984 and is headquartered in Jakarta Pusat, Indonesia.
Nitrasanata Dharma Tbk management
10- Dr. Johan A. M. M. HutaurukPresident Director · born 1968
- Mr. Budi Djatmiko Musaffa B.B.A.Finance Director & Director · born 1960
- Dr. Emma RusmayaniHead of Cibubur
- Dr. Devina Nur AnnisaHead of Tambora
- Dr. Nashrul IhsanHead of Bekasi
- Dr. Zeiras Eka DjamalHead of Cinere
- Dr. Andhika Guna DharmaHead of Candi Eye Center, Semarang
- Dr. Dian ArumdiniHead of JEC JAVA @ Surabaya
- Dr. Kukuh PrasetyoHead of JEC Anwari @ Purwokerto
- Dr. Ardy GisnawanHead of JEC Orbita @ Makassar